These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27821417)

  • 21. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcified Neoatherosclerosis Causing "Undilatable" In-Stent Restenosis: Insights of Optical Coherence Tomography and Role of Rotational Atherectomy.
    Bastante T; Rivero F; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2039-2040. PubMed ID: 26738675
    [No Abstract]   [Full Text] [Related]  

  • 23. High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.
    Vanags LZ; Wong NKP; Nicholls SJ; Bursill CA
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1691-1701. PubMed ID: 29954755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
    Kang SH; Kang SJ; Kim WJ
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
    [No Abstract]   [Full Text] [Related]  

  • 25. Neoatherosclerosis causing occlusive in-stent restenosis: Impact of intracoronary imaging in the intensity of lipid-lowering therapy.
    Martí D; López E; Álvarez S; Palazuelos J; Rada I; Alfonso F
    Cardiovasc Revasc Med; 2016 Dec; 17(8):584-585. PubMed ID: 27743816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis.
    Ng J; Bourantas CV; Torii R; Ang HY; Tenekecioglu E; Serruys PW; Foin N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2231-2242. PubMed ID: 29122816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early In-Stent Restenosis Due to Delayed Protrusion of Underlying Atheromatous Plaque.
    Otagaki M; Matsumura K; Fujii K; Kin H; Yamamoto Y; Shiojima I
    Circ J; 2019 Aug; 83(9):1971. PubMed ID: 30853680
    [No Abstract]   [Full Text] [Related]  

  • 29. Temporal course of vessel healing and neoatherosclerosis after DES implantation.
    Kozuki A; Shinke T; Otake H; Shite J; Nakagawa M; Nagoshi R; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hirata KI
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1121-1123. PubMed ID: 24135328
    [No Abstract]   [Full Text] [Related]  

  • 30. Multimodality visualization with 3-dimensional reconstruction of neointimal plaque rupture after bare-metal stent implantation.
    Sudo M; Hiro T; Takayama T; Iida K; Nishida T; Kawano T; Kanai T; Higuchi Y; Hirayama A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e163-5. PubMed ID: 25240542
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
    Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
    Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography.
    Ellert J; Antonsen L; Jensen LO
    Cardiovasc Revasc Med; 2017; 18(3):207-211. PubMed ID: 27650886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.
    Gil RJ; Bil J; Legutko J; Pawłowski T; Gil KE; Dudek D; Costa RA
    Int J Cardiovasc Imaging; 2018 Mar; 34(3):353-365. PubMed ID: 28965166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of preinterventional plaque composition and eccentricity on late-acquired incomplete stent apposition after sirolimus-eluting stent implantation: an intravascular ultrasound radiofrequency analysis.
    Sato T; Kameyama T; Noto T; Nozawa T; Inoue H
    Coron Artery Dis; 2012 Nov; 23(7):432-7. PubMed ID: 22936019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.